================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 11, 2005
BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-10783 75-1590407
------------------------------- ------------ -------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
2188 West 2200 South
Salt Lake City, Utah 84119
------------------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (801) 972-5555
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
This Current Report on Form 8-K/A amends Item 5.02 of the Current Report on Form
8-K filed with the Securities and Exchange Commission on May 16, 2005 (the "Form
8-K Report"), reporting the appointment of Douglas P. Boyd, Ph.D. to the Board
of Directors of BSD Medical Corporation. The Form 8-K Report is hereby amended
to restate such item as set forth herein.
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
On May 11, 2005, the Board of Directors (the "Board") of BSD Medical Corporation
(the "Company") elected Douglas P. Boyd, Ph.D. to the Board to serve until the
next annual meeting of shareholders. The Board has not yet determined which
Board committee or committees Dr. Boyd will join. There is no arrangement or
understanding between Dr. Boyd and any other individual pursuant to which Dr.
Boyd was selected as a director, and there are no related party transactions
between the Company and Dr. Boyd reportable under Item 404(a) of Regulation S-B.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 1, 2005
BSD MEDICAL CORPORATION
By: Hyrum A. Mead
--------------
Name: Hyrum A. Mead
Title: President
EXHIBIT INDEX
Exhibit No. Description
----------- -----------------------------------------------------------------
99.1 Press Release of BSD Medical Corporation dated May 16, 2005.